Piper Sandler, HubSpot
Piper Sandler analyst Clarke Jeffries raised the firm’s price ... the firm notes. As such, the company expects the second half of the year subscription revenue to return to 8%-10% year-over-year ...
Fastly (FSLY) shares slipped fractionally in premarket trading on Thursday, even as investment firm Piper Sandler upped its ...
Harbor Capital Advisors Inc. lifted its holdings in Piper Sandler Companies (NYSE:PIPR – Free Report) by 1.1% during the ...
Piper Sandler lowered the firm’s price target on Bloomin’ Brands (BLMN) to $16 from $20 and keeps a Neutral rating on the shares following the company earnings report. The firm says results for ...
Celanese (NYSE:CE) -4.7% in Friday's trading to its lowest in more than four years after Piper Sandler downgrades shares to ...
Piper Sandler Companies (NYSE:PIPR), a leading investment bank and institutional securities firm, has demonstrated resilience and strategic growth in a dynamic financial landscape. The company's ...
Good morning and welcome to the Piper Sandler Company's third quarter, 2024 earnings conference call. Today's call is being recorded and will include remarks by Piper Sandler management followed ...
Piper Sandler Companies (PIPR) came out with quarterly earnings of $2.57 per share, beating the Zacks Consensus Estimate of $2.53 per share. This compares to earnings of $1.76 per share a year ago ...
These are among the recent developments for CVB Financial, as the company maintains its proactive approach in navigating the financial landscape. To complement Piper Sandler's analysis ...
Piper Sandler noted that Fastly’s guidance for Q4 remained consistent, a shift from previous quarters when the company ...
In a report released today, David Amsellem from Piper Sandler reiterated a Hold rating on Pacira Pharmaceuticals (PCRX – Research Report), with a price target of $12.00. The company’s shares ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback